| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 5.55e-06 | 13 | 55 | 3 | GO:0016717 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.93e-04 | 194 | 55 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | protein prenyltransferase activity | 2.06e-04 | 8 | 55 | 2 | GO:0008318 | |
| Domain | FA_desaturase_dom | 1.41e-06 | 8 | 56 | 3 | IPR005804 | |
| Domain | FA_desaturase | 1.41e-06 | 8 | 56 | 3 | PF00487 | |
| Domain | PFTA | 2.64e-05 | 3 | 56 | 2 | PS51147 | |
| Domain | TIF_eIF_4E_CS | 2.64e-05 | 3 | 56 | 2 | IPR019770 | |
| Domain | Prenyl_trans_a | 2.64e-05 | 3 | 56 | 2 | IPR002088 | |
| Domain | PPTA | 2.64e-05 | 3 | 56 | 2 | PF01239 | |
| Domain | Fatty_acid_desaturase | 2.64e-05 | 3 | 56 | 2 | IPR012171 | |
| Domain | IF4E | 5.28e-05 | 4 | 56 | 2 | PS00813 | |
| Domain | IF4E | 5.28e-05 | 4 | 56 | 2 | PF01652 | |
| Domain | - | 8.78e-05 | 5 | 56 | 2 | 3.30.760.10 | |
| Domain | TIF_eIF_4E | 8.78e-05 | 5 | 56 | 2 | IPR001040 | |
| Domain | TIF_eIF4e-like | 8.78e-05 | 5 | 56 | 2 | IPR023398 | |
| Domain | Ferric_reduct | 5.72e-04 | 12 | 56 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 5.72e-04 | 12 | 56 | 2 | IPR013130 | |
| Domain | CYTOCHROME_B5_2 | 6.74e-04 | 13 | 56 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 6.74e-04 | 13 | 56 | 2 | PS00191 | |
| Domain | Cyt-b5 | 7.85e-04 | 14 | 56 | 2 | PF00173 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 7.85e-04 | 14 | 56 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 7.85e-04 | 14 | 56 | 2 | SM01117 | |
| Domain | - | 7.85e-04 | 14 | 56 | 2 | 3.10.120.10 | |
| Domain | - | 2.95e-03 | 27 | 56 | 2 | 2.130.10.80 | |
| Domain | Gal_Oxidase_b-propeller | 4.66e-03 | 34 | 56 | 2 | IPR015916 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22698694 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28237083 | ||
| Pubmed | Placental expression of Fatty Acid Desaturases 1, 2 and 3 in selected pregnancy pathologies. | 8.48e-06 | 3 | 59 | 2 | 36652541 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 27269715 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10860662 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 22877655 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 21040914 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 24985009 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26286848 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 20562440 | ||
| Pubmed | Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair. | 1.69e-05 | 4 | 59 | 2 | 23303818 | |
| Pubmed | Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. | 1.69e-05 | 4 | 59 | 2 | 19148276 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 3.31e-05 | 736 | 59 | 8 | 29676528 | |
| Pubmed | Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. | 4.23e-05 | 6 | 59 | 2 | 21419114 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.94e-05 | 569 | 59 | 7 | 30639242 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 19376974 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 28039900 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 25194280 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.20e-04 | 454 | 59 | 6 | 33226137 | |
| Pubmed | A Human Pleiotropic Multiorgan Condition Caused by Deficient Wnt Secretion. | 1.54e-04 | 11 | 59 | 2 | 34587386 | |
| Pubmed | The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles. | 1.54e-04 | 11 | 59 | 2 | 25937288 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.82e-04 | 1203 | 59 | 9 | 29180619 | |
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 23147502 | ||
| Pubmed | 2.32e-04 | 326 | 59 | 5 | 17015433 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 23378610 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 29901792 | ||
| Pubmed | 3.79e-04 | 17 | 59 | 2 | 33084572 | ||
| Pubmed | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. | 4.75e-04 | 19 | 59 | 2 | 21623369 | |
| Pubmed | Wntless is required for peripheral lung differentiation and pulmonary vascular development. | 5.27e-04 | 20 | 59 | 2 | 23523683 | |
| Pubmed | Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. | 5.82e-04 | 21 | 59 | 2 | 24249740 | |
| Pubmed | 7.00e-04 | 23 | 59 | 2 | 22817342 | ||
| Pubmed | 7.43e-04 | 421 | 59 | 5 | 36976175 | ||
| Pubmed | Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. | 7.62e-04 | 24 | 59 | 2 | 20705733 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 7.62e-04 | 24 | 59 | 2 | 30190310 | |
| Pubmed | 7.62e-04 | 24 | 59 | 2 | 9606417 | ||
| Pubmed | 7.69e-04 | 105 | 59 | 3 | 9628581 | ||
| Pubmed | Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy. | 7.90e-04 | 106 | 59 | 3 | 33087821 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 8.28e-04 | 25 | 59 | 2 | 2283726 | |
| Pubmed | 8.34e-04 | 108 | 59 | 3 | 22082156 | ||
| Pubmed | 8.96e-04 | 26 | 59 | 2 | 17875933 | ||
| Pubmed | 8.96e-04 | 26 | 59 | 2 | 8218172 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 9.18e-04 | 1201 | 59 | 8 | 35696571 | |
| Pubmed | Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation. | 1.04e-03 | 28 | 59 | 2 | 20434207 | |
| Pubmed | 1.11e-03 | 952 | 59 | 7 | 38569033 | ||
| Pubmed | 1.12e-03 | 29 | 59 | 2 | 20972250 | ||
| Pubmed | 1.12e-03 | 29 | 59 | 2 | 21829377 | ||
| Pubmed | 1.18e-03 | 467 | 59 | 5 | 30194290 | ||
| Pubmed | 1.19e-03 | 30 | 59 | 2 | 32645484 | ||
| Pubmed | 1.19e-03 | 30 | 59 | 2 | 19401682 | ||
| Pubmed | 1.53e-03 | 34 | 59 | 2 | 11101529 | ||
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 1.53e-03 | 34 | 59 | 2 | 19060911 | |
| GeneFamily | Fatty acid desaturases | 2.80e-07 | 8 | 32 | 3 | 553 | |
| GeneFamily | Prenyltransferase alpha subunit repeat containing | 9.09e-06 | 3 | 32 | 2 | 687 | |
| GeneFamily | Kelch like|BTB domain containing | 2.50e-03 | 42 | 32 | 2 | 617 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.65e-07 | 200 | 59 | 6 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-06 | 177 | 59 | 5 | 6248c0dcad302de61a66163ee84b3b79096150d7 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.78e-06 | 186 | 59 | 5 | a7a2ef8392a045a62fa4d0983577711d5d397dc4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-06 | 189 | 59 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.30e-06 | 190 | 59 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.30e-06 | 190 | 59 | 5 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.44e-06 | 191 | 59 | 5 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.44e-06 | 191 | 59 | 5 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 192 | 59 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 193 | 59 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-06 | 194 | 59 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | distal-3-Endothelial-Lymphatic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.32e-06 | 197 | 59 | 5 | 9ea0e2ed9c3f97591a06e70570640996580417d5 | |
| ToppCell | distal-Endothelial-Lymphatic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.32e-06 | 197 | 59 | 5 | 8f2e19409ebe9a490d5a245fa82c765ed6d77c3e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.64e-06 | 199 | 59 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 1ec2f322f936d2501330c53bb7c9390216c50cd1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | e250b2e45ef869f81cc40cc41f53d1e54e7848aa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 111 | 59 | 4 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 159 | 59 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 159 | 59 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 172 | 59 | 4 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 8.15e-05 | 173 | 59 | 4 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.90e-05 | 177 | 59 | 4 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 8.90e-05 | 177 | 59 | 4 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.70e-05 | 181 | 59 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-05 | 182 | 59 | 4 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 182 | 59 | 4 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-05 | 182 | 59 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-05 | 182 | 59 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 182 | 59 | 4 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 183 | 59 | 4 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 183 | 59 | 4 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 183 | 59 | 4 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 184 | 59 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-04 | 185 | 59 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-04 | 185 | 59 | 4 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 186 | 59 | 4 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 186 | 59 | 4 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 186 | 59 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 186 | 59 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 187 | 59 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 59 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-04 | 187 | 59 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 187 | 59 | 4 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 187 | 59 | 4 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 189 | 59 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 189 | 59 | 4 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.15e-04 | 189 | 59 | 4 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 189 | 59 | 4 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | droplet-Bladder|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 170484f7a6f0a0d0792bbe1bb04abad060b7188e | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | c03c735a0ed850bf460a1847f5e2dd61753e577d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 190 | 59 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-04 | 191 | 59 | 4 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | b842647caf05d39f602de83c647d5c224715d19f | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 191 | 59 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 191 | 59 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 192 | 59 | 4 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 192 | 59 | 4 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 192 | 59 | 4 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 192 | 59 | 4 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 192 | 59 | 4 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-04 | 192 | 59 | 4 | 567f4355a01aae1f2eafc16fe86d1538a62030ab | |
| ToppCell | Epithelial|World / shred on cell class and cell subclass (v4) | 1.22e-04 | 192 | 59 | 4 | 13a3553d9a7c78535679d23d454c63fd08f7d218 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 192 | 59 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 193 | 59 | 4 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 193 | 59 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 193 | 59 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | 44ba79db566d0fa3bbcfe3adf9164bf8c3cb0bc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 194 | 59 | 4 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 194 | 59 | 4 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 194 | 59 | 4 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 194 | 59 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 194 | 59 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.29e-04 | 195 | 59 | 4 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 1.32e-04 | 196 | 59 | 4 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.32e-04 | 196 | 59 | 4 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 196 | 59 | 4 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 196 | 59 | 4 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 196 | 59 | 4 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| Disease | eicosapentaenoic acid measurement | 3.12e-05 | 31 | 58 | 3 | EFO_0007760 | |
| Disease | lysophosphatidylcholine 24:0 measurement | 5.67e-05 | 6 | 58 | 2 | EFO_0021463 | |
| Disease | level of Phosphatidylcholine (16:0_18:0) in blood serum | 5.67e-05 | 6 | 58 | 2 | OBA_2045069 | |
| Disease | level of Phosphatidylcholine (16:1_20:4) in blood serum | 5.67e-05 | 6 | 58 | 2 | OBA_2045084 | |
| Disease | cholesteryl ester 18:3 measurement | 6.76e-05 | 40 | 58 | 3 | EFO_0010346 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:1) in blood serum | 7.92e-05 | 7 | 58 | 2 | OBA_2045133 | |
| Disease | lysophosphatidylcholine 22:4 measurement | 7.92e-05 | 7 | 58 | 2 | EFO_0021461 | |
| Disease | phosphatidylcholine 35:5 measurement | 7.92e-05 | 7 | 58 | 2 | EFO_0021472 | |
| Disease | cholesteryl ester 20:4 measurement | 9.01e-05 | 44 | 58 | 3 | EFO_0010348 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 1.06e-04 | 8 | 58 | 2 | OBA_2045147 | |
| Disease | phosphatidylcholine 39:5 measurement | 1.35e-04 | 9 | 58 | 2 | EFO_0021476 | |
| Disease | level of Phosphatidylcholine (18:2_20:1) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045107 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045130 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045077 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045095 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 1.69e-04 | 10 | 58 | 2 | OBA_2045148 | |
| Disease | cholesteryl ester 22:4 measurement | 1.69e-04 | 10 | 58 | 2 | EFO_0021443 | |
| Disease | cholesteryl ester 22:5 measurement | 1.69e-04 | 10 | 58 | 2 | EFO_0021444 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 2.06e-04 | 11 | 58 | 2 | OBA_2045123 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 2.06e-04 | 11 | 58 | 2 | EFO_0021458 | |
| Disease | cholesteryl ester 20:2 measurement | 2.47e-04 | 12 | 58 | 2 | EFO_0021440 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 2.92e-04 | 13 | 58 | 2 | OBA_2045116 | |
| Disease | bronchopulmonary dysplasia (is_implicated_in) | 2.92e-04 | 13 | 58 | 2 | DOID:11650 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.92e-04 | 13 | 58 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 3.40e-04 | 14 | 58 | 2 | OBA_2045102 | |
| Disease | diacylglycerol 38:4 measurement | 3.40e-04 | 14 | 58 | 2 | EFO_0020066 | |
| Disease | vascular dementia (biomarker_via_orthology) | 3.40e-04 | 14 | 58 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 3.92e-04 | 15 | 58 | 2 | OBA_2045131 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 3.92e-04 | 15 | 58 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 3.92e-04 | 15 | 58 | 2 | EFO_0800508 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.92e-04 | 15 | 58 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | decreased susceptibility to hepatitis C infection | 4.48e-04 | 16 | 58 | 2 | EFO_0010101 | |
| Disease | preeclampsia, parental genotype effect measurement | 4.48e-04 | 16 | 58 | 2 | EFO_0000668, EFO_0005939 | |
| Disease | phosphatidylcholine 36:4 measurement | 5.69e-04 | 18 | 58 | 2 | EFO_0010382 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 5.69e-04 | 18 | 58 | 2 | OBA_2045110 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 5.69e-04 | 18 | 58 | 2 | OBA_2045079 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 6.36e-04 | 19 | 58 | 2 | OBA_2045199 | |
| Disease | diacylglycerol 38:5 measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0020065 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 6.36e-04 | 19 | 58 | 2 | MONDO_0018469 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045156 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045076 | |
| Disease | metabolite measurement | 7.98e-04 | 560 | 58 | 6 | EFO_0004725 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 9.36e-04 | 23 | 58 | 2 | OBA_2045158 | |
| Disease | phosphatidylserines measurement | 9.36e-04 | 23 | 58 | 2 | EFO_0020049 | |
| Disease | alpha-linolenic acid measurement | 1.11e-03 | 25 | 58 | 2 | EFO_0007759 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 1.20e-03 | 26 | 58 | 2 | EFO_0010369 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 1.20e-03 | 26 | 58 | 2 | OBA_2045087 | |
| Disease | docosapentaenoic acid measurement | 1.29e-03 | 27 | 58 | 2 | EFO_0006809 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 1.39e-03 | 28 | 58 | 2 | OBA_2045139 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 1.49e-03 | 29 | 58 | 2 | EFO_0010370 | |
| Disease | Myeloid Leukemia, Chronic | 1.49e-03 | 29 | 58 | 2 | C0023473 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 1.70e-03 | 31 | 58 | 2 | OBA_2045198 | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 1.70e-03 | 31 | 58 | 2 | OBA_2045094 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 1.81e-03 | 32 | 58 | 2 | EFO_0010363 | |
| Disease | cholesteryl ester 22:6 measurement | 1.81e-03 | 32 | 58 | 2 | EFO_0010350 | |
| Disease | phosphatidylcholine 38:5 measurement | 1.93e-03 | 33 | 58 | 2 | EFO_0010387 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.93e-03 | 33 | 58 | 2 | DOID:10283 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHNVWESHAWRQRLP | 871 | Q68DN1 | |
| HWLHLWRPQTKDGNS | 41 | Q6ZSB3 | |
| PTSFHRKWWGLNLQF | 711 | P41180 | |
| WDVGSHFKIRPLWQH | 66 | Q8IVW1 | |
| AAGKSFHHLWPQGQW | 181 | Q8N1I8 | |
| FHHLWPQGQWASKPR | 186 | Q8N1I8 | |
| FLHPNWASHRANWIK | 921 | Q12830 | |
| NFLEKNLWHMWVHPH | 196 | O75355 | |
| FPHWWHLPFTNSDHR | 1261 | O75747 | |
| PVVRNAALFWWNLHR | 486 | Q7Z4N8 | |
| KQQPIWHTLRFWNAA | 296 | O60268 | |
| HNLWAQRLARQHPDW | 256 | Q9NRD9 | |
| KGASANWWNHRHFQH | 206 | O95864 | |
| NWWNHRHFQHHAKPN | 211 | O95864 | |
| HARWAPQQDWHWARR | 381 | Q86Y97 | |
| LHPLQNRWALWFFKN | 61 | A6NMX2 | |
| HWNAPEHLAWLKQAV | 1651 | O60318 | |
| KHPLQNRWALWFFKN | 36 | P06730 | |
| KEALPSWLHWDSQSH | 101 | Q14118 | |
| AHTARAQLPFWNNWT | 181 | P56645 | |
| KWLLANPQHHSKWLD | 236 | Q9P2G9 | |
| TWWQAKHEADANPRA | 271 | Q5T2T1 | |
| LLHWNGRHKPWDFPS | 311 | Q9H1C3 | |
| KIRWRWFGHQASSPN | 61 | Q96PQ7 | |
| QDWFDAWVSKLRHHR | 166 | Q9BZF3 | |
| PATAFRWWQPQHGKH | 1571 | P78509 | |
| RWWQPQHGKHSAQWA | 1576 | P78509 | |
| FRWHQPAPFDKQQTW | 2456 | P78509 | |
| KALPRLHAWFSWLHQ | 536 | Q13724 | |
| LHAWFSWLHQSQAGP | 541 | Q13724 | |
| FDWPARHWNAKYLSQ | 51 | Q96EW2 | |
| TNWRKHNLHSWVLHF | 651 | A4D1B5 | |
| QLRFWKHWHSRQPTA | 296 | Q8TE85 | |
| HTHFKNIPIGFWWAV | 381 | P48547 | |
| HLPQHHSWVKVLWDF | 286 | Q6QHC5 | |
| ARWHDESHLNKFFWL | 286 | U3KPV4 | |
| HAHNGWIPKSNLWLK | 241 | Q9HBU6 | |
| QLKGFSAHWWNFRHF | 206 | Q9Y5Q0 | |
| KPHFHKDWQRRVATW | 11 | P26373 | |
| RFNWKLFWQFLHPHL | 131 | Q9NUT2 | |
| SLWAPGHNRSWHKVA | 376 | Q9P2B2 | |
| ELSPSFHQKNWQHWF | 501 | Q5ST30 | |
| QQHGVTLLHRFWNLW | 411 | A8K8P3 | |
| HLRHPHNWVWLTAAQ | 2471 | O75691 | |
| NAWSHRIWVLQHLAK | 196 | Q7Z6K3 | |
| AWFQKTQAHWLLQHG | 76 | Q9NP31 | |
| TQAHWLLQHGAAPAW | 81 | Q9NP31 | |
| HAWQHRQWVIQEFKL | 201 | P49354 | |
| DWIPKVWHHLNRFLE | 2316 | Q8IVL1 | |
| LEANPNAWLQNHAHW | 131 | Q495M3 | |
| VAGRWTTPNHHIWKQ | 2381 | Q9UKZ4 | |
| QVLKQNPFWWTHQRH | 1446 | Q6P2Q9 | |
| NPFWWTHQRHDGKLW | 1451 | Q6P2Q9 | |
| IHSFPNRSRFWKHEW | 101 | O00584 | |
| HIVHNWKARWFILRQ | 16 | Q9NYT0 | |
| FPDWLDHWLQHRKQI | 291 | Q658P3 | |
| HPFFKNDQWHWDNIR | 351 | O75116 | |
| KANYWWLRHHPQVLS | 461 | P31939 | |
| NWRHHPAVVEQWSKV | 226 | Q86X10 | |
| NSLFDSRGWPLWHEH | 551 | Q9HCJ5 | |
| VAALRFEWAWQHPHA | 76 | Q9BQ83 | |
| FEWAWQHPHASRRLA | 81 | Q9BQ83 | |
| NHHKTKWFVPWGPNH | 56 | Q5T9L3 | |
| HLNYHQKAPARWEWL | 76 | Q5T742 | |
| QPTIKWFWHPCNHNH | 461 | P17948 | |
| WNASFIQHQKWHTRK | 451 | Q8N2I2 | |
| RRSFLDFDPHHFWQW | 126 | Q8N2U9 | |
| FTVAWKLLRHAQWDH | 166 | Q8WUU4 | |
| QHWRHHGFWRKKIQP | 51 | Q8N402 |